Interesting article on the effects of the Covid vaccine on immunotherapy patients being treated for cancer and tumors.
COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research
Clinical outcomes for patients with late-stage melanoma are very promising, according to the article.
"Remarkably, patients who received either the Pfizer or Moderna mRNA-based COVID-19 vaccine within 100 days of starting immunotherapy were more than twice as likely to be alive after three years, compared with those who didn’t receive either vaccine. Surprisingly, patients with tumors that don’t typically respond well to immunotherapy also saw very strong benefits, with nearly fivefold improvement in three-year overall survival.
This link between improved survival and receiving a COVID-19 mRNA vaccine remained strong even after we controlled for factors like disease severity and co-occurring conditions."
